Cargando…

Correlation Between Quantitative MRI and Muscle Histopathology in Muscle Biopsies from Healthy Controls and Patients with IBM, FSHD and OPMD

BACKGROUND: Muscle MRI is increasingly used as a diagnostic and research tool in muscle disorders. However, the correlation between MRI abnormalities and histopathological severity is largely unknown. OBJECTIVE: To investigate correlations between muscle MRI abnormalities and histopathological sever...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lassche, Saskia, Küsters, Benno, Heerschap, Arend, Schyns, Maxime V.P., Ottenheijm, Coen A.C., Voermans, Nicol C., van Engelen, Baziel G.M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2020
Materias:	Research Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7739972/ https://www.ncbi.nlm.nih.gov/pubmed/32925090 http://dx.doi.org/10.3233/JND-200543

Ejemplares similares

Reduced specific force in patients with mild and severe facioscapulohumeral muscular dystrophy
por: Lassche, Saskia, et al.
Publicado: (2020)

MRI-Guided Biopsy as a Tool for Diagnosis and Research of Muscle Disorders
por: Lassche, Saskia, et al.
Publicado: (2018)

Inspiratory Muscle Training in Nemaline Myopathy
por: van Kleef, Esmee S.B., et al.
Publicado: (2023)

Determining the role of sarcomeric proteins in facioscapulohumeral muscular dystrophy: a study protocol
por: Lassche, Saskia, et al.
Publicado: (2013)

Facioscapulohumeral dystrophy transcriptome signatures correlate with different stages of disease and are marked by different MRI biomarkers
por: van den Heuvel, Anita, et al.
Publicado: (2022)

Five‐year follow‐up study on quantitative muscle magnetic resonance imaging in facioscapulohumeral muscular dystrophy: The link to clinical outcome
por: Vincenten, Sanne C.C., et al.
Publicado: (2023)

FSHD / OPMD / MYOTONIC DYSTROPHY: P.229 Open-Label study of losmapimod evaluating safety, tolerability, and changes in biomarker and clinical outcome assessments in subjects with FSHD1
por: Mellion, M., et al.
Publicado: (2020)

Monitoring creatine and phosphocreatine by (13)C MR spectroscopic imaging during and after (13)C4 creatine loading: a feasibility study
por: Janssen, Barbara H., et al.
Publicado: (2016)

The FSHD muscle–blood biomarker: a circulating transcriptomic biomarker for clinical severity in facioscapulohumeral muscular dystrophy
por: Banerji, Christopher R S, et al.
Publicado: (2023)

The facioscapulohumeral muscular dystrophy Rasch‐built overall disability scale (FSHD‐RODS)
por: Mul, Karlien, et al.
Publicado: (2021)

Reproducibility and robustness of motor cortical stimulation to assess muscle relaxation kinetics
por: Molenaar, Joery P., et al.
Publicado: (2022)

Deregulation of the ubiquitin-proteasome system is the predominant molecular pathology in OPMD animal models and patients
por: Anvar, Seyed Yahya, et al.
Publicado: (2011)

Inhibition of myostatin improves muscle atrophy in oculopharyngeal muscular dystrophy (OPMD)
por: Harish, Pradeep, et al.
Publicado: (2019)

Dysfunctional transcripts are formed by alternative polyadenylation in OPMD
por: Raz, Vered, et al.
Publicado: (2017)

Lower extremity muscle pathology in myotonic dystrophy type 1 assessed by quantitative MRI
por: Heskamp, Linda, et al.
Publicado: (2019)

Effect of aerobic exercise training and cognitive behavioural therapy on reduction of chronic fatigue in patients with facioscapulohumeral dystrophy: protocol of the FACTS-2-FSHD trial
por: Voet, Nicoline BM, et al.
Publicado: (2010)

The double homeodomain protein DUX4c is associated with regenerating muscle fibers and RNA-binding proteins
por: Claus, Clothilde, et al.
Publicado: (2023)

Quantitative muscle MRI and ultrasound for facioscapulohumeral muscular dystrophy: complementary imaging biomarkers
por: Mul, Karlien, et al.
Publicado: (2018)

Meeting report: the 2020 FSHD International Research Congress
por: Kyba, Michael, et al.
Publicado: (2020)

Super relaxed myosins loosen up to different cues in cardiac and skeletal muscle sarcomeres
por: Claassen, Wout J., et al.
Publicado: (2023)

Facioscapulohumeral dystrophy in children: design of a prospective, observational study on natural history, predictors and clinical impact (iFocus FSHD)
por: Goselink, Rianne J. M., et al.
Publicado: (2016)

Orofacial Muscle Weakening in Facioscapulohumeral Muscular Dystrophy (FSHD) Patients
por: Konstantonis, Dimitrios, et al.
Publicado: (2022)

Altered Expression of Cyclin A 1 In Muscle of Patients with Facioscapulohumeral Muscle Dystrophy (FSHD-1)
por: Pakula, Anna, et al.
Publicado: (2013)

miRNA Expression in Control and FSHD Fetal Human Muscle Biopsies
por: Portilho, Débora Morueco, et al.
Publicado: (2015)

A decline in PABPN1 induces progressive muscle weakness in Oculopharyngeal muscle dystrophy and in muscle aging
por: Anvar, Seyed Yahya, et al.
Publicado: (2013)

DUX4 expressing immortalized FSHD lymphoblastoid cells express genes elevated in FSHD muscle biopsies, correlating with the early stages of inflammation
por: Banerji, Christopher R S, et al.
Publicado: (2020)

Distinct Disease Phases in Muscles of Facioscapulohumeral Dystrophy Patients Identified by MR Detected Fat Infiltration
por: Janssen, Barbara H., et al.
Publicado: (2014)

New Insights into the Structural Roles of Nebulin in Skeletal Muscle
por: Ottenheijm, Coen A. C., et al.
Publicado: (2010)

Whole-muscle fat analysis identifies distal muscle end as disease initiation site in facioscapulohumeral muscular dystrophy
por: Heskamp, Linda, et al.
Publicado: (2022)

DUX4 Binding to Retroelements Creates Promoters That Are Active in FSHD Muscle and Testis
por: Young, Janet M., et al.
Publicado: (2013)

DUX4 Expression in FSHD Muscles: Focus on Its mRNA Regulation
por: Sidlauskaite, Eva, et al.
Publicado: (2020)

Muscle Fiber Conduction Velocity Correlates With the Age at Onset in Mild FSHD Cases
por: Beretta-Piccoli, Matteo, et al.
Publicado: (2021)

Author Correction: Whole-muscle fat analysis identifies distal muscle end as disease initiation site in facioscapulohumeral muscular dystrophy
por: Heskamp, Linda, et al.
Publicado: (2023)

Novel Metabolomic Approach for Identifying Pathology-Specific Biomarkers in Rare Diseases: A Case Study in Oculopharyngeal Muscular Dystrophy (OPMD)
por: Harish, Pradeep, et al.
Publicado: (2023)

A bright light on myosin to study skeletal muscle relaxation
por: Galli, Ricardo A., et al.
Publicado: (2020)

Myoblasts from affected and non-affected FSHD muscles exhibit morphological differentiation defects
por: Barro, Marietta, et al.
Publicado: (2010)

An in silico FSHD muscle fiber for modeling DUX4 dynamics and predicting the impact of therapy
por: Cowley, Matthew V, et al.
Publicado: (2023)

Muscle Ultrasound Abnormalities in Individuals with RYR1-Related Malignant Hyperthermia Susceptibility
por: van den Bersselaar, Luuk R., et al.
Publicado: (2023)

Systemic cell therapy for muscular dystrophies: The ultimate transplantable muscle progenitor cell and current challenges for clinical efficacy
por: Ausems, C. Rosanne M., et al.
Publicado: (2020)

Indications for Tube Feeding in Adults with Muscular Disorders: A Scoping Review
por: Middelink, Marloes, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_pq4iqc8sqrmc2vaoou47m8qfne